
Opinion|Videos|July 12, 2024
Limitations on Optimal Biomarker Testing Rates
A panel of experts discuss the current limitations of optimal biomarker testing rates in the community.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What may currently limit optimal biomarker testing rates in the community?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
2
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
3
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
4
White House to Announce Second Drug Pricing Deal as AstraZeneca Joins TrumpRx
5